Syncromune, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer (NCT06533644) | Syncromune, Inc. | 2025-05-29 |
Track Syncromune, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.